3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
30
Nivolumab
11
atezolizumab
8
Docetaxel
8
Cisplatin
7
Carboplatin
7
Gemcitabine
6
fludarabine
5
Trastuzumab
5
Paclitaxel
5
Ipilimumab
5
Fluorouracil
5
Cyclophosphamide
5
spartalizumab
4
cemiplimab
4
avelumab
4
Polymerase Chain Reaction
4
Cetuximab
4
Capecitabine
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
aldesleukin
3
Taxes
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Interleukin-2
3
Gene Expression Profiling
3
Drug Therapy
3
Biopsy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Radionuclide Imaging
×
Head & Neck
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled